iRhythm Technologies shares are trading lower. Goldman Sachs initiated coverage on the stock with a Neutral rating and announced a price target of $78.
Portfolio Pulse from Benzinga Newsdesk
iRhythm Technologies shares declined after Goldman Sachs initiated coverage with a Neutral rating and set a price target of $78.
October 04, 2024 | 7:07 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Goldman Sachs initiated coverage on iRhythm Technologies with a Neutral rating and a price target of $78, leading to a decline in the stock price.
The Neutral rating from a major financial institution like Goldman Sachs can influence investor sentiment negatively, especially if the market expected a more positive outlook. The price target of $78 may also be below current market expectations, contributing to the stock's decline.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100